LEGEND BIOTECH CORP's ticker is LEGN and the CUSIP is 52490G102. A total of 140 filers reported holding LEGEND BIOTECH CORP in Q1 2022. The put-call ratio across all filers is 1.23 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $18,542,346 | -3.6% | 276,051 | -0.9% | 0.01% | 0.0% |
| Q2 2023 | $19,226,511 | +47.0% | 278,524 | +2.7% | 0.01% | +20.0% |
| Q1 2023 | $13,083,628 | +16.8% | 271,332 | +21.0% | 0.01% | +25.0% |
| Q4 2022 | $11,197,604 | +27.6% | 224,311 | +4.3% | 0.00% | +33.3% |
| Q3 2022 | $8,774,000 | -23.3% | 215,059 | +3.4% | 0.00% | -25.0% |
| Q2 2022 | $11,435,000 | +74.3% | 207,895 | +15.1% | 0.00% | +100.0% |
| Q1 2022 | $6,562,000 | -5.1% | 180,583 | +21.7% | 0.00% | 0.0% |
| Q4 2021 | $6,915,000 | +5432.0% | 148,370 | +5885.1% | 0.00% | – |
| Q3 2021 | $125,000 | +22.5% | 2,479 | 0.0% | 0.00% | – |
| Q2 2021 | $102,000 | +6.2% | 2,479 | -24.7% | 0.00% | – |
| Q1 2021 | $96,000 | +3.2% | 3,294 | 0.0% | 0.00% | – |
| Q4 2020 | $93,000 | – | 3,294 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 1,629,173 | $66,470,000 | 19.56% |
| MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 1,466,453 | $59,831,000 | 8.69% |
| Paradigm Biocapital Advisors LP | 1,076,591 | $43,925,000 | 5.86% |
| HHLR ADVISORS, LTD. | 5,136,617 | $209,574,000 | 5.51% |
| RA Capital Management | 2,338,610 | $95,415,000 | 2.04% |
| Nicholas Investment Partners, LP | 399,486 | $16,299,000 | 1.51% |
| Parkman Healthcare Partners LLC | 121,227 | $4,946,000 | 1.41% |
| Capital International, Inc./CA/ | 1,244,362 | $50,770,000 | 1.13% |
| AtonRa Partners | 28,150 | $1,149,000 | 1.13% |
| Vivo Capital, LLC | 244,375 | $9,971,000 | 1.10% |